A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma
Clinical trial NCT00193492 · COMPLETED
Trial details
- NCT number
- NCT00193492
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2013-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.